Indian Pharmacopoiea commission (IPC) informed that there will be no legal action taken on Adverse drug reaction (ADR) reporter. And active participation in ADR reporting is needed from all healthcare professionals, as IPC concern.
IPC an autonomous institution of Ministry of Health and Family Welfare, Government of India has been entrusted with the responsibility relating to Pharmacovigilance Programme of India (PvPI) since April 2011. The Objective of PvPl is to improve patient safety and welfare of Indian population by monitoring drug safety and thereby reducing the risks associated with the use of medicines.
The Pharmacovigilance and Adverse Drug Reaction (ADR) reporting among healthcare professionals needs to be sealed up. It can be done by developing educational and promotional interventions like continuous medical education, awareness programme, workshops, conferences on pharmacovigilance, etc.
IPC said in a notification that "Pharmacovigilance is based on sound scientific principles and is an integral part of effective clinical practices. The discipline need to develop further to meet the demands of public health for which continuous monitoring of drugs is essentials. Such monitoring will help in assessing, monitoring and detecting adverse effects of drugs, their interactions etc. that can result in higher morbidity and mortality. The initiative will help to maximize benefits and minimize risks associated with drugs."
it is emphasized that reporting of adverse events shall not have any legal obligation on reporter, therefore your active participation in ADR reporting is need of the hour.
